Company Filing History:
1 out of 832,812 Years Active: 2010
Title: Michael Muehlebach: Innovator in Gene Transfer Technology
Introduction
Michael Muehlebach is a notable inventor based in Schoeneck, Germany. He has made significant contributions to the field of gene transfer technology, particularly through his work on lentiviral vectors. His innovative approach has implications for gene therapy and cellular biology.
Latest Patents
Muehlebach holds a patent for "Lentiviral vectors derived from SIVsmm/PBj14, method for their production and uses thereof." This invention relates to retroviral vectors, specifically lentiviral vectors, which are utilized to transfer genes into cells that are in the G0 phase of the cell cycle. The vectors are derived from the simian immunodeficiency virus of the sooty mangabey monkey, strain PBj 14. This technology has the potential to enhance gene delivery methods in mammalian cells.
Career Highlights
Throughout his career, Muehlebach has focused on advancing the methodologies for gene transfer. His work has been instrumental in developing techniques that improve the efficiency and effectiveness of gene therapy applications. His patent reflects his commitment to innovation in this critical area of biotechnology.
Collaborations
Muehlebach has collaborated with esteemed colleagues such as Klaus Cichutek and Matthias Schweizer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in the field of gene transfer technology.
Conclusion
Michael Muehlebach is a pioneering inventor whose work on lentiviral vectors has the potential to transform gene therapy practices. His contributions to the field are significant and continue to influence research and development in biotechnology.